Skip to main content
. 2016 Oct 24;16:407. doi: 10.1186/s12906-016-1398-0

Table 2.

Effect of FXM on antioxidant enzymes of liver in rat

Treatment CAT (U/min) POD (U/min) SOD (U/mg protein) GST (mM/min/mg protein) GSR (mM//min/mg protein)
Control 3.88 ± 0.53ab 9.55 ± 0.99ab 3.00 ± 0.31a 160.81 ± 8.53a 224.62 ± 9.02a
DMSO + Olive oil 4.19 ± 0.27a 10.65 ± 1.44ab 3.07 ± 0.27a 158.56 ± 11.67a 220.11 ± 8.01a
CCl4 2.33 ± 0.18†c 5.31 ± 0.63†c 1.30 ± 0.23†c 100.11 ± 4.99†c 130.52 ± 9.77†d
CCl4 + silymarin (100 mg/kg) 3.88 ± 0.28ab 9.31 ± 0.67ab 2.93 ± 0.23ab 151.02 ± 9.49ab 180.88 ± 9.17†c
CCl4 + FXM (200 mg/kg) 2.64 ± 0.15†c 7.45 ± 0.39†b 1.58 ± 0.11†c 133.85 ± 8.34†b 184.83 ± 8.90†c
CCl4 + FXM (400 mg/kg) 3.37 ± 0.24*b 9.01 ± 0.55ab 2.46 ± 0.19≠b 150.70 ± 8.98ab 198.03 ± 10.64†bc
FXM (200 mg/kg) 3.79 ± 0.23ab 9.44 ± 0.87ab 2.99 ± 0.18a 159.57 ± 9.57a 221.17 ± 7.15a
FXM (400 mg/kg) 3.91 ± 0.45ab 9.59 ± 0.75ab 2.94 ± 0.20ab 159.66 ± 9.63a 216.03 ± 8.42ab

FXM F. xanthoxyloides methanol extract. Data values shown represent mean ± SD (n = 6). One way analysis of variance was followed by Dunnet comparison of various treatments with control at: *, P < 0.05; #, P < 0.01; ǂ, P < 0.001. Multiple comparisons among treatments were determined by Tukeys’ HSD test. Superscript alphabets indicate significance among treatments (P < 0.01) on not sharing common letter